Quit Smoking Text Message Study

Yale University

Status: Completed

Conditions: Smoking Cessation

Treatments: Other: SmokefreeTXT; Device: Smartband

Study type: Interventional

Funder types: Other

Identifiers

NCT06111755

IA-1049344 (Other Grant/Funding Number)

2000035868

Details and patient eligibility

About

This project will address research gaps and advance the science of smoking cessation by conducting a randomized controlled trial of an evidence-based, population-level quit smoking text messaging program with or without a smartband.

Full description

Aim 1 of this study is to test within-treatment effects for smoking cessation. The primary outcome will be biochemically (cotinine)-confirmed 7-day point-prevalence abstinence (PPA) at end of treatment (8 weeks). Secondary outcomes will be percent days smoke-free, time to relapse, and rated treatment satisfaction.

Aim 2 of this study is to explore sex/gender differences in treatment effects for smoking cessation. Given established sex/gender differences in smoking behavior and cessation,randomization will be stratified by sex/gender and we will measure effects of sex/gender on outcomes. Effect sizes will be estimated for smoking outcomes by sex.

Outcomes will be evaluated for those who complete enrollment, defined as those who complete study onboarding.

Enrollment: 204 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• daily smokers for at least 6 months
• report an interest in quitting smoking.

Exclusion criteria

• reporting being currently enrolled in another quit smoking program

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

204 participants in 2 patient groups

SmokefreeTXT

Active Comparator group

Description:

Daily smokers for at least 6 months who report an interest in quitting will be randomized to receive the National Cancer Institute's SmokefreeTXT.

Treatment:

Other: SmokefreeTXT

SmokefreeTXT + smartband

Experimental group

Description:

Daily smokers for at least 6 months who report an interest in quitting will be randomized to receive the National Cancer Institute's SmokefreeTXT + smartband.

Treatment:

Device: Smartband

Other: SmokefreeTXT